Related Experiment Videos
Quantitation of erythrocyte-bound IgG by competitive solid-phase enzyme immunoassay
K Adachi1, Y Horii, H Nagatomo
1Departments of Veterinary Internal Medicine, Miyazaki University, Japan.
The Journal of Veterinary Medical Science
|June 1, 1994
Summary
A new enzyme immunoassay accurately measures erythrocyte-bound IgG. Anemic dogs showed higher levels of this immunoglobulin G, indicating its potential as a biomarker for anemia.
Area of Science:
- Immunology
- Veterinary Medicine
- Biochemistry
Background:
- Erythrocyte-bound immunoglobulin G (IgG) plays a role in autoimmune hemolytic anemia.
- Accurate quantitation of RBC-bound IgG is crucial for diagnosing and understanding hemolytic conditions.
- Existing methods for measuring RBC-bound IgG may lack sensitivity or simplicity.
Purpose of the Study:
- To develop and validate a competitive solid-phase enzyme immunoassay for quantifying erythrocyte-bound IgG.
- To assess the sensitivity, reproducibility, and simplicity of the developed immunoassay.
- To compare RBC-bound IgG levels in anemic dogs with positive Coombs' test results versus healthy dogs.
Main Methods:
- A competitive solid-phase enzyme immunoassay technique was employed.
- The assay was optimized for sensitivity and reproducibility.
- Quantification of IgG concentration (ng/ml) on red blood cells (RBCs) was performed.
Main Results:
- The developed immunoassay demonstrated high sensitivity and reproducibility.
- The method proved to be simpler to perform compared to existing techniques.
- Anemic dogs with positive Coombs' tests exhibited significantly higher RBC-bound IgG values than healthy controls.
Conclusions:
- The novel enzyme immunoassay provides a sensitive, reproducible, and simpler method for quantifying RBC-bound IgG.
- Elevated RBC-bound IgG levels are associated with anemia and a positive Coombs' test in dogs.
- This assay has potential applications in the diagnosis and management of immune-mediated anemias in veterinary medicine.